OTCMKTS:SHJBF Shanghai Junshi Biosciences (SHJBF) Stock Price, News & Analysis C$1.86 0.00 (0.00%) (As of 07/5/2024 ET) Add Compare Share Share Today's RangeC$1.86▼C$1.8650-Day RangeC$1.86▼C$1.8652-Week RangeC$0.95▼C$2.06VolumeN/AAverage Volume100 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Shanghai Junshi Biosciences alerts: Email Address Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. About Shanghai Junshi Biosciences Stock (OTCMKTS:SHJBF)Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, autoimmune, neurologic, nervous system, and infectious diseases in the People's Republic of China. The company was founded in 2012 and is headquartered in Shanghai, People's Republic of China.Read More SHJBF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHJBF Stock News HeadlinesApril 26, 2024 | wsj.comShanghai Junshi Biosciences Co. Ltd.April 24, 2024 | finance.yahoo.comJunshi Biosciences Announces NDA Acceptance in Hong Kong for ToripalimabJuly 6, 2024 | Crypto 101 Media (Ad)Top Hedge Funds Reveal A.I. Moonshot CoinsThe manager of top crypto hedge fund Pantera recently said every crypto company will soon be an artificial intelligence venture… And there are a handful of little-known crypto projects in the A.I. sector that they expect to benefit the most during this wave. February 2, 2024 | finance.yahoo.comJunshi Biosciences Announces Toripalimab’s NDA Accepted by the Singapore Health Sciences AuthorityJanuary 18, 2024 | finance.yahoo.comJunshi Biosciences Announces JAMA Publication of Results from NEOTORCH, a Randomized Phase 3 Trial of Perioperative Toripalimab plus Chemotherapy for Patients with Resectable Non-Small Cell Lung CancerJanuary 11, 2024 | investing.comShanghai Junshi Biosciences Co Ltd (1877)January 10, 2024 | finance.yahoo.comJunshi Biosciences Announces Publication of Results from TORCHLIGHT, a Randomized Phase 3 Trial of Toripalimab for the Treatment of Metastatic or Recurrent Triple-negative Breast Cancer in Nature MedicineJanuary 6, 2024 | forbes.comShanghai LujianziJuly 6, 2024 | Crypto 101 Media (Ad)Top Hedge Funds Reveal A.I. Moonshot CoinsThe manager of top crypto hedge fund Pantera recently said every crypto company will soon be an artificial intelligence venture… And there are a handful of little-known crypto projects in the A.I. sector that they expect to benefit the most during this wave. January 5, 2024 | travel.usnews.comWhat to Eat in ShanghaiJanuary 5, 2024 | msn.comInovio stock surges to seven-month highJanuary 2, 2024 | finance.yahoo.comJunshi Biosciences Announces Approval of the Supplemental New Drug Application for Toripalimab as Perioperative Treatment for Resectable NSCLC PatientsDecember 12, 2023 | bbc.comHow long will Shanghai's lockdown last?December 3, 2023 | seekingalpha.comWeek In Review: Tang Capital Offers $465M For LianBio Plus 80% Of Any Licenses/DivestmentsDecember 1, 2023 | finance.yahoo.comJunshi Biosciences Announces New Chemical Entity Application for Toripalimab Accepted by Australia’s TGANovember 28, 2023 | msn.comCoherus cancer drug undercuts Merck's KeytrudaNovember 22, 2023 | finance.yahoo.comJunshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19October 31, 2023 | msn.comCoherus, Shanghai Junshi Shares Gain After U.S. Approval For Nasopharyngeal Cancer DrugSee More Headlines Receive SHJBF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shanghai Junshi Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:SHJBF CUSIPN/A CIKN/A Webwww.junshipharma.com Phone86 21 6105 8800FaxN/AEmployees2,568Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report Key ExecutivesMr. Jun Xiong (Age 50)Executive Chairman Comp: $1MMr. Cong Li (Age 60)Co-CEO & Executive Director Comp: $594.65kDr. Jianjun Zou M.D. (Age 53)Ph.D., GM, CEO & Executive Director Comp: $825.1kDr. Ning Li (Age 63)Executive Vice-Chairman of the Board Comp: $1.03MMr. Baohong Xu (Age 45)Financial Director Mr. Zhuobing Zhang (Age 57)Deputy GM & Executive Director Comp: $949.12kDr. Sheng Yao Ph.D. (Age 49)Senior VP & Executive Director Comp: $652.93kDr. Gang Wang (Age 67)Deputy GM, Chief Quality Officer, Senior VP of Industry Affairs & Executive Director Comp: $160.06kDr. Xin Li (Age 45)Executive Director Ms. Lu Yuan (Age 42)Assistant to GM & Chief of Internal Audit Department More ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors SHJBF Stock Analysis - Frequently Asked Questions How have SHJBF shares performed this year? Shanghai Junshi Biosciences' stock was trading at C$2.15 on January 1st, 2024. Since then, SHJBF stock has decreased by 13.5% and is now trading at C$1.86. View the best growth stocks for 2024 here. How do I buy shares of Shanghai Junshi Biosciences? Shares of SHJBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHJBF) was last updated on 7/6/2024 by MarketBeat.com Staff From Our PartnersWhy Conservative Americans Are Turning to Gold in 2024Welcome to the financial rollercoaster of 2024, where inflation is relentless, stock markets are inflated, and...All American Assets | Sponsored50-year Wall Street Legend Issues July Stock WarningJuly is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredNvidia’s Quiet $1 Trillion PivotNvidia recently added $277 billion in market cap … IN ONE DAY.Weiss Ratings | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredBill Gates is all about this tiny $2 stockWhat does Bill Gates know about this tiny company that we don’t? From the outside, it looks like a worthles...Timothy Sykes | SponsoredGrab Your Free Bitcoin Today!And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a v...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shanghai Junshi Biosciences Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shanghai Junshi Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
